Paper7517879
Lymphocyte populations and immune responses in CD5-deficient mice.
Tarakhovsky A and 2 others. Eur J Immunol, 1994. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Lymphocyte populations and immune responses in CD5-deficient mice. Papers, record 7517879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7517879
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Immunoglobulin Isotypes | Major topic |
| Lymphocyte Subsets | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Antibody Affinity | |
| Base Sequence | |
| CD5 Antigens | |
| Flow Cytometry | |
| Mice | |
| Mice, Mutant Strains | |
| Molecular Sequence Data |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39471840 | Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants. | Open Biol | 2024 | https://conductscience.org/library/papers/39471840 | PubMed |
| 37159521 | THEMIS increases TCR signaling in CD4+CD8+ thymocytes by inhibiting the activity of the tyrosine phosphatase SHP1. | Sci Signal | 2023 | https://conductscience.org/library/papers/37159521 | PubMed |
| 36211446 | Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. | Front Immunol | 2022 | https://conductscience.org/library/papers/36211446 | PubMed |
| 35720357 | CD5 Controls Gut Immunity by Shaping the Cytokine Profile of Intestinal T Cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720357 | PubMed |
| 34274536 | The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains. | Mol Ther | 2021 | https://conductscience.org/library/papers/34274536 | PubMed |
| 32513716 | CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32513716 | PubMed |
| 31433296 | TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections. | Elife | 2019 | https://conductscience.org/library/papers/31433296 | PubMed |
| 30619347 | CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation. | Front Immunol | 2018 | https://conductscience.org/library/papers/30619347 | PubMed |
| 29723108 | Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration. | Cancer Biol Ther | 2018 | https://conductscience.org/library/papers/29723108 | PubMed |
| 29618523 | Tuning T Cell Signaling Sensitivity Alters the Behavior of CD4+ T Cells during an Immune Response. | J Immunol | 2018 | https://conductscience.org/library/papers/29618523 | PubMed |
| 28672038 | T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. | PLoS One | 2017 | https://conductscience.org/library/papers/28672038 | PubMed |
| 27793593 | Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells. | Immunity | 2016 | https://conductscience.org/library/papers/27793593 | PubMed |
| 26697015 | Functional Heterogeneity in CD4(+) T Cell Responses Against a Bacterial Pathogen. | Front Immunol | 2015 | https://conductscience.org/library/papers/26697015 | PubMed |
| 23483035 | T-cell modulatory properties of CD5 and its role in antitumor immune responses. | Oncoimmunology | 2013 | https://conductscience.org/library/papers/23483035 | PubMed |
| 22904299 | CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. | J Immunol | 2012 | https://conductscience.org/library/papers/22904299 | PubMed |
| 22003198 | Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens. | J Immunol | 2011 | https://conductscience.org/library/papers/22003198 | PubMed |
| 21076064 | A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells. | J Immunol | 2010 | https://conductscience.org/library/papers/21076064 | PubMed |
| 19541367 | CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. | Mol Immunol | 2009 | https://conductscience.org/library/papers/19541367 | PubMed |
| 17142752 | CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. | J Immunol | 2006 | https://conductscience.org/library/papers/17142752 | PubMed |
| 14694195 | Thymic selection can compensate for mutations affecting T cell activation and generate a normal T cell repertoire in mutant mice. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/14694195 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7517879
GET https://conductscience.org/api/papers/v1/7517879/cited_by?page=2